Tag: Cancer: Laryngeal
Oropharyngeal Cancer Incidence, Mortality Up Among U.S. Men
Geographic differences seen, with notable rises in the Midwest and Southeast
Incidence of Oropharyngeal Cancer Projected to Rise in U.S. Men
Under a status quo scenario based on current levels of HPV vaccination, 792,000 OPC cases in men would be prevented by the year 2100
Epigenetic Age Acceleration Up in Head and Neck Cancer
Correlation found for increased EAA with elevated fatigue, which was mediated by inflammatory markers CRP, IL-6
GERD Linked to Squamous Cell Cancers of Larynx, Esophagus
An estimated 16.92 and 17.32 percent, respectively, of cases of LSCC and ESCC among individuals aged 50 to 71 years linked to GERD
Timing, Intensity of Oral Sex Are Risk Factors for HPV-OPC
Increased odds of human papillomavirus oropharyngeal cancer seen for younger age at first oral sex, oral sex intensity
Head and Neck Cancer Surgery Seems Safe During COVID-19
Links seen for severe pulmonary complications in COVID-19-positive patients with advanced tumor stage, critical care admission
Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer
Outcomes and survival improved for early-stage oropharyngeal cancer, but not other cancers
CDC: 2009 to 2017 Saw Increase in Oral Cavity, Pharynx Cancers
Incidence dropped for cancers of lip, floor of mouth, soft palate and uvula, hard palate, hypopharynx, nasopharynx
Race, Insurance Status Linked to Lower Cancer Survival
Reduced survival seen in HPV-associated head and neck cancer for nonwhite, uninsured patients
Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
